Predicting fluid needs while lying face down in ARDS
Part of Lungs & breathing clinical trials.
This study tests a way to predict whether you will benefit from a fluid bolus (a small amount of IV fluid) while you are lying face down for ARDS. It uses continuous heart monitoring to guide or evaluate fluid decisions and may help clinicians avoid too much or too little fluid.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (including if you are under legal protection/wardship)
- You have ARDS, a serious lung condition diagnosed using standard Berlin criteria
- You are currently lying face down (prone) following international guidelines
- You have a calibrated continuous heart output monitoring device in place
- A clinician wants to try a fluid bolus because you show at least two signs like mottled skin, fast heart rate, low blood pressure, low urine, low cardiac output, or high blood lactate
- You are not making breathing efforts (no spontaneous respiratory effort)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a specific breathing event (“avalanche phenomenon”) when the lungs are opened in people with early, moderate-to-severe ARDS. The goal is to understand what’s happening in the lungs and whether it can guide better care.
This study compares lying face down continuously for a long time versus lying face down for shorter periods each day. It is for patients with moderate to severe ARDS (a serious lung condition) who are on a breathing machine. The goal is to see which approach helps the lungs recover better.
This trial tests if longer periods of lying face-down (prone positioning) can help people with ARDS who are on a breathing machine. It aims to improve oxygen levels and possibly reduce the need for more invasive treatments.
This trial studies how lying on your stomach (prone positioning) affects blood flow in the brain during severe lung failure (ARDS). It aims to predict and prevent brain problems that might occur with this treatment.
This trial tests a quick breathing maneuver during surgery to see if it can guide how much fluid to give, aiming to improve recovery and stability.
This trial uses ultrasound to see if a small change in breathing can predict how your body will respond to fluids. It could help doctors decide if you need more fluids or not.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.